Drug Shortage Report for ANDROGEL
Report ID | 82221 |
Drug Identification Number | 02245346 |
Brand name | ANDROGEL |
Common or Proper name | TESTOSTERONE |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE |
Strength(s) | 1% |
Dosage form(s) | GEL |
Route of administration | TRANSDERMAL |
Packaging size | 30 |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2019-06-03 |
Actual start date | |
Estimated end date | 2019-06-15 |
Actual end date | 2019-05-28 |
Shortage status | Avoided shortage |
Updated date | 2019-05-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2019-05-28 | French | Compare |
v8 | 2019-05-28 | English | Compare |
v7 | 2019-05-14 | French | Compare |
v6 | 2019-05-14 | English | Compare |
v5 | 2019-05-07 | English | Compare |
v4 | 2019-04-30 | French | Compare |
v3 | 2019-04-30 | English | Compare |
v2 | 2019-04-23 | French | Compare |
v1 | 2019-04-23 | English | Compare |
Showing 1 to 9 of 9